 | • レポートコード：MRC2-11QY09397 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は血清がんバイオマーカーのグローバル市場について調査・分析したレポートです。種類別（肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓および胆道癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他）市場規模、用途別（病院、学術研究機関、外来外科センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別血清がんバイオマーカーの競争状況、市場シェア ・世界の血清がんバイオマーカー市場：種類別市場規模 2015年-2020年（肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓および胆道癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他） ・世界の血清がんバイオマーカー市場：種類別市場規模予測 2021年-2026年（肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓および胆道癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他） ・世界の血清がんバイオマーカー市場：用途別市場規模 2015年-2020年（病院、学術研究機関、外来外科センター、その他） ・世界の血清がんバイオマーカー市場：用途別市場規模予測 2021年-2026年（病院、学術研究機関、外来外科センター、その他） ・北米の血清がんバイオマーカー市場分析：米国、カナダ ・ヨーロッパの血清がんバイオマーカー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの血清がんバイオマーカー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の血清がんバイオマーカー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの血清がんバイオマーカー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Pfizer、Novartis、Abbott、BD、Merck、Eli Lilly、Agilent Technologies、Boehringer Ingelheim、AstraZeneca、Bristol-Myers Squibb、Novo Nordisk、Allergan、Gilead ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Serum biomarkers are proteins generally detected in urine, blood, and other bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within high risk population, diagnosis of specific type of cancer, prediction in its growth, screen its treatment response, and detect early recurrence.
The global serum cancer biomarkers market is projected to grow at a rapid pace in the next few years. Key drivers of the market are increase in the number of people suffering from different types of cancer and rise in the geriatric population. Increase in the cancer-afflicted population is anticipated to be another key driver of the market.
Market Analysis and Insights: Global Serum Cancer Biomarkers Market
The global Serum Cancer Biomarkers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Serum Cancer Biomarkers Scope and Market Size
Serum Cancer Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Serum Cancer Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Serum Cancer Biomarkers market is segmented into
Hepatocellular Carcinoma Serum Biomarkers
Lung Cancer Serum Biomarkers
Pancreatic & Biliary Tract Cancer Serum Biomarkers
Breast Cancer Serum Biomarkers
Glioblastoma Serum Biomarkers
Others
Segment by Application, the Serum Cancer Biomarkers market is segmented into
Hospitals
Academic & Research Institutes
Ambulatory Surgical Centers
Others
Regional and Country-level Analysis
The Serum Cancer Biomarkers market is analysed and market size information is provided by regions (countries).
The key regions covered in the Serum Cancer Biomarkers market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Serum Cancer Biomarkers Market Share Analysis
Serum Cancer Biomarkers market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Serum Cancer Biomarkers business, the date to enter into the Serum Cancer Biomarkers market, Serum Cancer Biomarkers product introduction, recent developments, etc.
The major vendors covered:
Roche
Pfizer
Novartis
Abbott
BD
Merck
Eli Lilly
Agilent Technologies
Boehringer Ingelheim
AstraZeneca
Bristol-Myers Squibb
Novo Nordisk
Allergan
Gilead
1 Study Coverage
1.1 Serum Cancer Biomarkers Product Introduction
1.2 Market Segments
1.3 Key Serum Cancer Biomarkers Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Serum Cancer Biomarkers Market Size Growth Rate by Type
1.4.2 Hepatocellular Carcinoma Serum Biomarkers
1.4.3 Lung Cancer Serum Biomarkers
1.4.4 Pancreatic & Biliary Tract Cancer Serum Biomarkers
1.4.5 Breast Cancer Serum Biomarkers
1.4.6 Glioblastoma Serum Biomarkers
1.4.7 Others
1.5 Market by Application
1.5.1 Global Serum Cancer Biomarkers Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Academic & Research Institutes
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Serum Cancer Biomarkers Market Size, Estimates and Forecasts
2.1.1 Global Serum Cancer Biomarkers Revenue 2015-2026
2.1.2 Global Serum Cancer Biomarkers Sales 2015-2026
2.2 Global Serum Cancer Biomarkers, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Serum Cancer Biomarkers Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Serum Cancer Biomarkers Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Serum Cancer Biomarkers Competitor Landscape by Players
3.1 Serum Cancer Biomarkers Sales by Manufacturers
3.1.1 Serum Cancer Biomarkers Sales by Manufacturers (2015-2020)
3.1.2 Serum Cancer Biomarkers Sales Market Share by Manufacturers (2015-2020)
3.2 Serum Cancer Biomarkers Revenue by Manufacturers
3.2.1 Serum Cancer Biomarkers Revenue by Manufacturers (2015-2020)
3.2.2 Serum Cancer Biomarkers Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Serum Cancer Biomarkers Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Serum Cancer Biomarkers Revenue in 2019
3.2.5 Global Serum Cancer Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Serum Cancer Biomarkers Price by Manufacturers
3.4 Serum Cancer Biomarkers Manufacturing Base Distribution, Product Types
3.4.1 Serum Cancer Biomarkers Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Serum Cancer Biomarkers Product Type
3.4.3 Date of International Manufacturers Enter into Serum Cancer Biomarkers Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Serum Cancer Biomarkers Market Size by Type (2015-2020)
4.1.1 Global Serum Cancer Biomarkers Sales by Type (2015-2020)
4.1.2 Global Serum Cancer Biomarkers Revenue by Type (2015-2020)
4.1.3 Serum Cancer Biomarkers Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Serum Cancer Biomarkers Market Size Forecast by Type (2021-2026)
4.2.1 Global Serum Cancer Biomarkers Sales Forecast by Type (2021-2026)
4.2.2 Global Serum Cancer Biomarkers Revenue Forecast by Type (2021-2026)
4.2.3 Serum Cancer Biomarkers Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Serum Cancer Biomarkers Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Serum Cancer Biomarkers Market Size by Application (2015-2020)
5.1.1 Global Serum Cancer Biomarkers Sales by Application (2015-2020)
5.1.2 Global Serum Cancer Biomarkers Revenue by Application (2015-2020)
5.1.3 Serum Cancer Biomarkers Price by Application (2015-2020)
5.2 Serum Cancer Biomarkers Market Size Forecast by Application (2021-2026)
5.2.1 Global Serum Cancer Biomarkers Sales Forecast by Application (2021-2026)
5.2.2 Global Serum Cancer Biomarkers Revenue Forecast by Application (2021-2026)
5.2.3 Global Serum Cancer Biomarkers Price Forecast by Application (2021-2026)
6 North America
6.1 North America Serum Cancer Biomarkers by Country
6.1.1 North America Serum Cancer Biomarkers Sales by Country
6.1.2 North America Serum Cancer Biomarkers Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Serum Cancer Biomarkers Market Facts & Figures by Type
6.3 North America Serum Cancer Biomarkers Market Facts & Figures by Application
7 Europe
7.1 Europe Serum Cancer Biomarkers by Country
7.1.1 Europe Serum Cancer Biomarkers Sales by Country
7.1.2 Europe Serum Cancer Biomarkers Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Serum Cancer Biomarkers Market Facts & Figures by Type
7.3 Europe Serum Cancer Biomarkers Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Serum Cancer Biomarkers by Region
8.1.1 Asia Pacific Serum Cancer Biomarkers Sales by Region
8.1.2 Asia Pacific Serum Cancer Biomarkers Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Serum Cancer Biomarkers Market Facts & Figures by Type
8.3 Asia Pacific Serum Cancer Biomarkers Market Facts & Figures by Application
9 Latin America
9.1 Latin America Serum Cancer Biomarkers by Country
9.1.1 Latin America Serum Cancer Biomarkers Sales by Country
9.1.2 Latin America Serum Cancer Biomarkers Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Serum Cancer Biomarkers Market Facts & Figures by Type
9.3 Central & South America Serum Cancer Biomarkers Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Serum Cancer Biomarkers by Country
10.1.1 Middle East and Africa Serum Cancer Biomarkers Sales by Country
10.1.2 Middle East and Africa Serum Cancer Biomarkers Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Serum Cancer Biomarkers Market Facts & Figures by Type
10.3 Middle East and Africa Serum Cancer Biomarkers Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Serum Cancer Biomarkers Products Offered
11.1.5 Roche Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Serum Cancer Biomarkers Products Offered
11.2.5 Pfizer Related Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description and Business Overview
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Serum Cancer Biomarkers Products Offered
11.3.5 Novartis Related Developments
11.4 Abbott
11.4.1 Abbott Corporation Information
11.4.2 Abbott Description and Business Overview
11.4.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Abbott Serum Cancer Biomarkers Products Offered
11.4.5 Abbott Related Developments
11.5 BD
11.5.1 BD Corporation Information
11.5.2 BD Description and Business Overview
11.5.3 BD Sales, Revenue and Gross Margin (2015-2020)
11.5.4 BD Serum Cancer Biomarkers Products Offered
11.5.5 BD Related Developments
11.6 Merck
11.6.1 Merck Corporation Information
11.6.2 Merck Description and Business Overview
11.6.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck Serum Cancer Biomarkers Products Offered
11.6.5 Merck Related Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Corporation Information
11.7.2 Eli Lilly Description and Business Overview
11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly Serum Cancer Biomarkers Products Offered
11.7.5 Eli Lilly Related Developments
11.8 Agilent Technologies
11.8.1 Agilent Technologies Corporation Information
11.8.2 Agilent Technologies Description and Business Overview
11.8.3 Agilent Technologies Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Agilent Technologies Serum Cancer Biomarkers Products Offered
11.8.5 Agilent Technologies Related Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Description and Business Overview
11.9.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Boehringer Ingelheim Serum Cancer Biomarkers Products Offered
11.9.5 Boehringer Ingelheim Related Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Corporation Information
11.10.2 AstraZeneca Description and Business Overview
11.10.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AstraZeneca Serum Cancer Biomarkers Products Offered
11.10.5 AstraZeneca Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Serum Cancer Biomarkers Products Offered
11.1.5 Roche Related Developments
11.12 Novo Nordisk
11.12.1 Novo Nordisk Corporation Information
11.12.2 Novo Nordisk Description and Business Overview
11.12.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Novo Nordisk Products Offered
11.12.5 Novo Nordisk Related Developments
11.13 Allergan
11.13.1 Allergan Corporation Information
11.13.2 Allergan Description and Business Overview
11.13.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Allergan Products Offered
11.13.5 Allergan Related Developments
11.14 Gilead
11.14.1 Gilead Corporation Information
11.14.2 Gilead Description and Business Overview
11.14.3 Gilead Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Gilead Products Offered
11.14.5 Gilead Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Serum Cancer Biomarkers Market Estimates and Projections by Region
12.1.1 Global Serum Cancer Biomarkers Sales Forecast by Regions 2021-2026
12.1.2 Global Serum Cancer Biomarkers Revenue Forecast by Regions 2021-2026
12.2 North America Serum Cancer Biomarkers Market Size Forecast (2021-2026)
12.2.1 North America: Serum Cancer Biomarkers Sales Forecast (2021-2026)
12.2.2 North America: Serum Cancer Biomarkers Revenue Forecast (2021-2026)
12.2.3 North America: Serum Cancer Biomarkers Market Size Forecast by Country (2021-2026)
12.3 Europe Serum Cancer Biomarkers Market Size Forecast (2021-2026)
12.3.1 Europe: Serum Cancer Biomarkers Sales Forecast (2021-2026)
12.3.2 Europe: Serum Cancer Biomarkers Revenue Forecast (2021-2026)
12.3.3 Europe: Serum Cancer Biomarkers Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Serum Cancer Biomarkers Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Serum Cancer Biomarkers Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Serum Cancer Biomarkers Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Serum Cancer Biomarkers Market Size Forecast by Region (2021-2026)
12.5 Latin America Serum Cancer Biomarkers Market Size Forecast (2021-2026)
12.5.1 Latin America: Serum Cancer Biomarkers Sales Forecast (2021-2026)
12.5.2 Latin America: Serum Cancer Biomarkers Revenue Forecast (2021-2026)
12.5.3 Latin America: Serum Cancer Biomarkers Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Serum Cancer Biomarkers Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Serum Cancer Biomarkers Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Serum Cancer Biomarkers Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Serum Cancer Biomarkers Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Serum Cancer Biomarkers Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Serum Cancer Biomarkers Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Serum Cancer Biomarkers Market Segments
Table 2. Ranking of Global Top Serum Cancer Biomarkers Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Serum Cancer Biomarkers Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Hepatocellular Carcinoma Serum Biomarkers
Table 5. Major Manufacturers of Lung Cancer Serum Biomarkers
Table 6. Major Manufacturers of Pancreatic & Biliary Tract Cancer Serum Biomarkers
Table 7. Major Manufacturers of Breast Cancer Serum Biomarkers
Table 8. Major Manufacturers of Glioblastoma Serum Biomarkers
Table 9. Major Manufacturers of Others
Table 10. Global Serum Cancer Biomarkers Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Serum Cancer Biomarkers Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Serum Cancer Biomarkers Sales by Regions 2015-2020 (K Units)
Table 13. Global Serum Cancer Biomarkers Sales Market Share by Regions (2015-2020)
Table 14. Global Serum Cancer Biomarkers Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Serum Cancer Biomarkers Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global Serum Cancer Biomarkers Sales Share by Manufacturers (2015-2020)
Table 17. Global Serum Cancer Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Serum Cancer Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Serum Cancer Biomarkers as of 2019)
Table 19. Serum Cancer Biomarkers Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Serum Cancer Biomarkers Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Serum Cancer Biomarkers Price (2015-2020) (USD/Unit)
Table 22. Serum Cancer Biomarkers Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Serum Cancer Biomarkers Product Type
Table 24. Date of International Manufacturers Enter into Serum Cancer Biomarkers Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Serum Cancer Biomarkers Sales by Type (2015-2020) (K Units)
Table 27. Global Serum Cancer Biomarkers Sales Share by Type (2015-2020)
Table 28. Global Serum Cancer Biomarkers Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Serum Cancer Biomarkers Revenue Share by Type (2015-2020)
Table 30. Serum Cancer Biomarkers Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global Serum Cancer Biomarkers Sales by Application (2015-2020) (K Units)
Table 32. Global Serum Cancer Biomarkers Sales Share by Application (2015-2020)
Table 33. North America Serum Cancer Biomarkers Sales by Country (2015-2020) (K Units)
Table 34. North America Serum Cancer Biomarkers Sales Market Share by Country (2015-2020)
Table 35. North America Serum Cancer Biomarkers Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Serum Cancer Biomarkers Revenue Market Share by Country (2015-2020)
Table 37. North America Serum Cancer Biomarkers Sales by Type (2015-2020) (K Units)
Table 38. North America Serum Cancer Biomarkers Sales Market Share by Type (2015-2020)
Table 39. North America Serum Cancer Biomarkers Sales by Application (2015-2020) (K Units)
Table 40. North America Serum Cancer Biomarkers Sales Market Share by Application (2015-2020)
Table 41. Europe Serum Cancer Biomarkers Sales by Country (2015-2020) (K Units)
Table 42. Europe Serum Cancer Biomarkers Sales Market Share by Country (2015-2020)
Table 43. Europe Serum Cancer Biomarkers Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Serum Cancer Biomarkers Revenue Market Share by Country (2015-2020)
Table 45. Europe Serum Cancer Biomarkers Sales by Type (2015-2020) (K Units)
Table 46. Europe Serum Cancer Biomarkers Sales Market Share by Type (2015-2020)
Table 47. Europe Serum Cancer Biomarkers Sales by Application (2015-2020) (K Units)
Table 48. Europe Serum Cancer Biomarkers Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Serum Cancer Biomarkers Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific Serum Cancer Biomarkers Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Serum Cancer Biomarkers Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Serum Cancer Biomarkers Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Serum Cancer Biomarkers Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific Serum Cancer Biomarkers Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Serum Cancer Biomarkers Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific Serum Cancer Biomarkers Sales Market Share by Application (2015-2020)
Table 57. Latin America Serum Cancer Biomarkers Sales by Country (2015-2020) (K Units)
Table 58. Latin America Serum Cancer Biomarkers Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Serum Cancer Biomarkers Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Serum Cancer Biomarkers Revenue Market Share by Country (2015-2020)
Table 61. Latin America Serum Cancer Biomarkers Sales by Type (2015-2020) (K Units)
Table 62. Latin America Serum Cancer Biomarkers Sales Market Share by Type (2015-2020)
Table 63. Latin America Serum Cancer Biomarkers Sales by Application (2015-2020) (K Units)
Table 64. Latin America Serum Cancer Biomarkers Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Serum Cancer Biomarkers Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa Serum Cancer Biomarkers Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Serum Cancer Biomarkers Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Serum Cancer Biomarkers Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Serum Cancer Biomarkers Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa Serum Cancer Biomarkers Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Serum Cancer Biomarkers Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa Serum Cancer Biomarkers Sales Market Share by Application (2015-2020)
Table 73. Roche Corporation Information
Table 74. Roche Description and Major Businesses
Table 75. Roche Serum Cancer Biomarkers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Roche Product
Table 77. Roche Recent Development
Table 78. Pfizer Corporation Information
Table 79. Pfizer Description and Major Businesses
Table 80. Pfizer Serum Cancer Biomarkers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Pfizer Product
Table 82. Pfizer Recent Development
Table 83. Novartis Corporation Information
Table 84. Novartis Description and Major Businesses
Table 85. Novartis Serum Cancer Biomarkers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Novartis Product
Table 87. Novartis Recent Development
Table 88. Abbott Corporation Information
Table 89. Abbott Description and Major Businesses
Table 90. Abbott Serum Cancer Biomarkers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Abbott Product
Table 92. Abbott Recent Development
Table 93. BD Corporation Information
Table 94. BD Description and Major Businesses
Table 95. BD Serum Cancer Biomarkers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. BD Product
Table 97. BD Recent Development
Table 98. Merck Corporation Information
Table 99. Merck Description and Major Businesses
Table 100. Merck Serum Cancer Biomarkers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Merck Product
Table 102. Merck Recent Development
Table 103. Eli Lilly Corporation Information
Table 104. Eli Lilly Description and Major Businesses
Table 105. Eli Lilly Serum Cancer Biomarkers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Eli Lilly Product
Table 107. Eli Lilly Recent Development
Table 108. Agilent Technologies Corporation Information
Table 109. Agilent Technologies Description and Major Businesses
Table 110. Agilent Technologies Serum Cancer Biomarkers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Agilent Technologies Product
Table 112. Agilent Technologies Recent Development
Table 113. Boehringer Ingelheim Corporation Information
Table 114. Boehringer Ingelheim Description and Major Businesses
Table 115. Boehringer Ingelheim Serum Cancer Biomarkers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Boehringer Ingelheim Product
Table 117. Boehringer Ingelheim Recent Development
Table 118. AstraZeneca Corporation Information
Table 119. AstraZeneca Description and Major Businesses
Table 120. AstraZeneca Serum Cancer Biomarkers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. AstraZeneca Product
Table 122. AstraZeneca Recent Development
Table 123. Bristol-Myers Squibb Corporation Information
Table 124. Bristol-Myers Squibb Description and Major Businesses
Table 125. Bristol-Myers Squibb Serum Cancer Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Bristol-Myers Squibb Product
Table 127. Bristol-Myers Squibb Recent Development
Table 128. Novo Nordisk Corporation Information
Table 129. Novo Nordisk Description and Major Businesses
Table 130. Novo Nordisk Serum Cancer Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Novo Nordisk Product
Table 132. Novo Nordisk Recent Development
Table 133. Allergan Corporation Information
Table 134. Allergan Description and Major Businesses
Table 135. Allergan Serum Cancer Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. Allergan Product
Table 137. Allergan Recent Development
Table 138. Gilead Corporation Information
Table 139. Gilead Description and Major Businesses
Table 140. Gilead Serum Cancer Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 141. Gilead Product
Table 142. Gilead Recent Development
Table 143. Global Serum Cancer Biomarkers Sales Forecast by Regions (2021-2026) (K Units)
Table 144. Global Serum Cancer Biomarkers Sales Market Share Forecast by Regions (2021-2026)
Table 145. Global Serum Cancer Biomarkers Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 146. Global Serum Cancer Biomarkers Revenue Market Share Forecast by Regions (2021-2026)
Table 147. North America: Serum Cancer Biomarkers Sales Forecast by Country (2021-2026) (K Units)
Table 148. North America: Serum Cancer Biomarkers Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Europe: Serum Cancer Biomarkers Sales Forecast by Country (2021-2026) (K Units)
Table 150. Europe: Serum Cancer Biomarkers Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Asia Pacific: Serum Cancer Biomarkers Sales Forecast by Region (2021-2026) (K Units)
Table 152. Asia Pacific: Serum Cancer Biomarkers Revenue Forecast by Region (2021-2026) (US$ Million)
Table 153. Latin America: Serum Cancer Biomarkers Sales Forecast by Country (2021-2026) (K Units)
Table 154. Latin America: Serum Cancer Biomarkers Revenue Forecast by Country (2021-2026) (US$ Million)
Table 155. Middle East and Africa: Serum Cancer Biomarkers Sales Forecast by Country (2021-2026) (K Units)
Table 156. Middle East and Africa: Serum Cancer Biomarkers Revenue Forecast by Country (2021-2026) (US$ Million)
Table 157. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 158. Key Challenges
Table 159. Market Risks
Table 160. Main Points Interviewed from Key Serum Cancer Biomarkers Players
Table 161. Serum Cancer Biomarkers Customers List
Table 162. Serum Cancer Biomarkers Distributors List
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Serum Cancer Biomarkers Product Picture
Figure 2. Global Serum Cancer Biomarkers Sales Market Share by Type in 2020 & 2026
Figure 3. Hepatocellular Carcinoma Serum Biomarkers Product Picture
Figure 4. Lung Cancer Serum Biomarkers Product Picture
Figure 5. Pancreatic & Biliary Tract Cancer Serum Biomarkers Product Picture
Figure 6. Breast Cancer Serum Biomarkers Product Picture
Figure 7. Glioblastoma Serum Biomarkers Product Picture
Figure 8. Others Product Picture
Figure 9. Global Serum Cancer Biomarkers Sales Market Share by Application in 2020 & 2026
Figure 10. Hospitals
Figure 11. Academic & Research Institutes
Figure 12. Ambulatory Surgical Centers
Figure 13. Others
Figure 14. Serum Cancer Biomarkers Report Years Considered
Figure 15. Global Serum Cancer Biomarkers Market Size 2015-2026 (US$ Million)
Figure 16. Global Serum Cancer Biomarkers Sales 2015-2026 (K Units)
Figure 17. Global Serum Cancer Biomarkers Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Serum Cancer Biomarkers Sales Market Share by Region (2015-2020)
Figure 19. Global Serum Cancer Biomarkers Sales Market Share by Region in 2019
Figure 20. Global Serum Cancer Biomarkers Revenue Market Share by Region (2015-2020)
Figure 21. Global Serum Cancer Biomarkers Revenue Market Share by Region in 2019
Figure 22. Global Serum Cancer Biomarkers Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Serum Cancer Biomarkers Revenue in 2019
Figure 24. Serum Cancer Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Serum Cancer Biomarkers Sales Market Share by Type (2015-2020)
Figure 26. Global Serum Cancer Biomarkers Sales Market Share by Type in 2019
Figure 27. Global Serum Cancer Biomarkers Revenue Market Share by Type (2015-2020)
Figure 28. Global Serum Cancer Biomarkers Revenue Market Share by Type in 2019
Figure 29. Global Serum Cancer Biomarkers Market Share by Price Range (2015-2020)
Figure 30. Global Serum Cancer Biomarkers Sales Market Share by Application (2015-2020)
Figure 31. Global Serum Cancer Biomarkers Sales Market Share by Application in 2019
Figure 32. Global Serum Cancer Biomarkers Revenue Market Share by Application (2015-2020)
Figure 33. Global Serum Cancer Biomarkers Revenue Market Share by Application in 2019
Figure 34. North America Serum Cancer Biomarkers Sales Growth Rate 2015-2020 (K Units)
Figure 35. North America Serum Cancer Biomarkers Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Serum Cancer Biomarkers Sales Market Share by Country in 2019
Figure 37. North America Serum Cancer Biomarkers Revenue Market Share by Country in 2019
Figure 38. U.S. Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.S. Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 41. Canada Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Serum Cancer Biomarkers Market Share by Type in 2019
Figure 43. North America Serum Cancer Biomarkers Market Share by Application in 2019
Figure 44. Europe Serum Cancer Biomarkers Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Serum Cancer Biomarkers Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Serum Cancer Biomarkers Sales Market Share by Country in 2019
Figure 47. Europe Serum Cancer Biomarkers Revenue Market Share by Country in 2019
Figure 48. Germany Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Serum Cancer Biomarkers Market Share by Type in 2019
Figure 59. Europe Serum Cancer Biomarkers Market Share by Application in 2019
Figure 60. Asia Pacific Serum Cancer Biomarkers Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Serum Cancer Biomarkers Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Serum Cancer Biomarkers Sales Market Share by Region in 2019
Figure 63. Asia Pacific Serum Cancer Biomarkers Revenue Market Share by Region in 2019
Figure 64. China Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Serum Cancer Biomarkers Market Share by Type in 2019
Figure 87. Asia Pacific Serum Cancer Biomarkers Market Share by Application in 2019
Figure 88. Latin America Serum Cancer Biomarkers Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America Serum Cancer Biomarkers Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Serum Cancer Biomarkers Sales Market Share by Country in 2019
Figure 91. Latin America Serum Cancer Biomarkers Revenue Market Share by Country in 2019
Figure 92. Mexico Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 93. Mexico Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 95. Brazil Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 97. Argentina Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Serum Cancer Biomarkers Market Share by Type in 2019
Figure 99. Latin America Serum Cancer Biomarkers Market Share by Application in 2019
Figure 100. Middle East and Africa Serum Cancer Biomarkers Sales Growth Rate 2015-2020 (K Units)
Figure 101. Middle East and Africa Serum Cancer Biomarkers Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Serum Cancer Biomarkers Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Serum Cancer Biomarkers Revenue Market Share by Country in 2019
Figure 104. Turkey Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 105. Turkey Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 107. Saudi Arabia Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Serum Cancer Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 109. U.A.E Serum Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Serum Cancer Biomarkers Market Share by Type in 2019
Figure 111. Middle East and Africa Serum Cancer Biomarkers Market Share by Application in 2019
Figure 112. North America Serum Cancer Biomarkers Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. North America Serum Cancer Biomarkers Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Serum Cancer Biomarkers Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Europe Serum Cancer Biomarkers Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Serum Cancer Biomarkers Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Asia Pacific Serum Cancer Biomarkers Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Serum Cancer Biomarkers Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Latin America Serum Cancer Biomarkers Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Serum Cancer Biomarkers Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Middle East and Africa Serum Cancer Biomarkers Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
血清バイオマーカーの世界市場（～2026年） Serum biomarkers are proteins generally detected in urine, blood, and other bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within…- がん分子バイオマーカーの世界市場（～2026年） Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluid…
- 予測バイオマーカーの世界市場（～2026年） Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic. The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer. Mar…
- ゲノミクスバイオマーカーの世界市場（～2026年） A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characterist…
- 心臓バイオマーカーの世界市場（～2026年） Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These …